2000
DOI: 10.1038/79403
|View full text |Cite
|
Sign up to set email alerts
|

Biotechnology and the European public

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

20
248
4
14

Year Published

2002
2002
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 346 publications
(286 citation statements)
references
References 2 publications
20
248
4
14
Order By: Relevance
“…At the same time, lack of information about genetic engineering does not simply translate as rejection of it. 5 A similar picture emerges from US surveys, which show that the general attitudes toward biotechnology remain positive. Again, it is not so much the level of knowledge and scientific literacy which seems to determine attitudes toward biotechnology, but considerations of moral acceptability.…”
Section: How Society Sees Gene Therapymentioning
confidence: 62%
“…At the same time, lack of information about genetic engineering does not simply translate as rejection of it. 5 A similar picture emerges from US surveys, which show that the general attitudes toward biotechnology remain positive. Again, it is not so much the level of knowledge and scientific literacy which seems to determine attitudes toward biotechnology, but considerations of moral acceptability.…”
Section: How Society Sees Gene Therapymentioning
confidence: 62%
“…The public has become more involved in governance issues (Bingham et al, 2005;Bryson et al, 2014), and food safety and sustainability must be rigorously studied, measured, and standardized in cooperation with researchers, government, and civil society organizations (Fuchs et al, 2011). Transparency, accountability, and collaborative research could also serve to avoid "social amplification processes" that hindered the introduction of GM foods (Gaskell et al, 2000;Henson, 1995;Siegrist, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Risks that are unknown and potentially catastrophic should be given more weight than the simple statistics suggest, especially when there is no identified benefit; and benefit is an important part of the equation of public perception of risk. For instance, the public response to the use of genetic modification in medicines is very different to that for food (Gaskell et al 2000;Gaskell & Bauer 2001;Poortinga & Pidgeon 2003), probably because the medicines bring benefits while, at least for the moment, the foods do not.…”
Section: Perception Of Riskmentioning
confidence: 99%